Neuroscience 260:106119 Brekke EM, Morken TS, Wideroe M, Haberg AK, Brubakk AM, Sonnewald U (2014) The pentose phosphate pathway and pyruvate carboxylation after neonatal hypoxic-ischemic brain injury
Unlike tightly controlled clinical trials, real-life settings lack structured support, which often leads to lower adherence
Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
Cao et al
In Nederland zijn nu al injecteerbare semaglutide en tirzepatide beschikbaar via een arts
Only 100% pure, pharmaceutical-grade L-Glutamine is selectedfor inclusion in our formulary